OCPNY News and Press, Olympus Corp Sponsored ADR From 10/21/22

Olympus Announces Leadership Succession Plan TOKYO, Oct 21, 2022 - (ACN Newswire) - Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer and more fulfilling, today announced that Stefan Kaufmann, the current Director, Exec...

Olympus EU-ME3 Ultrasound Processor Delivers Higher Resolution Images for Endoscopic Ultrasound TOKYO & HAMBURG, Oct 7, 2022 - (JCN Newswire) - Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer and more fulfilling, ...

Olympus Launches THUNDERBEAT Energy Device for Open Surgery TOKYO and CENTER VALLEY, PA., Sept 28, 2022 - (JCN Newswire) - Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer, and more fulfilling, today announced the rele...

The following slide deck was published by Olympus Corporation in conjunction with their 2023 Q1 earnings call. For further details see: Olympus Corporation 2023 Q1 - Results - Earnings Call Presentation

Olympus Corporation (OCPNY) Q1 2023 Earnings Conference Call August 9, 2022 2:00 AM ET Company Participants Chikashi Takeda - Executive Officer & CFO Nacho Abia - COO & Executive Officer Conference Call Participants Presentation Chikashi...

Olympus Corporation press release ( OTCPK:OCPNY ): Q1 GAAP EPS of ¥19.52. Revenue of ¥214.06B (+11.8% Y/Y). For further details see: Olympus Corporation GAAP EPS of ¥19.52, revenue of ¥214.06B

The Great Multiple Contraction. The Great Disconnect: macro forces vs company fundamentals. The end of printing money and of asset inflation. A lot of growth stocks are very undervalued. Hervé van Caloen, CIO Mercator International Opportunity Fund Q2, 2...

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Growth stocks continued to trail value through challengin...

Growth stocks continued to trail value through challenging macro and market conditions but the magnitude of underperformance has been narrowing, supporting Strategy results. We are closely watching corporate results to determine the near-term outlook for international equities. How co...

Growth stocks continued to trail value through challenging macro and market conditions but the magnitude of underperformance has been narrowing, supporting Strategy results. To manage through the myriad uncertainties in the current environment, we continue to rely on secular and struc...